![Comparisons between the MRI (a) and FDG-PET (b) images of a 68-year-old... | Download Scientific Diagram Comparisons between the MRI (a) and FDG-PET (b) images of a 68-year-old... | Download Scientific Diagram](https://www.researchgate.net/profile/Ryuichi-Takahashi-3/publication/51880146/figure/fig3/AS:195701200953362@1423670210977/Comparisons-between-the-MRI-a-and-FDG-PET-b-images-of-a-68-year-old-male-patient-with.png)
Comparisons between the MRI (a) and FDG-PET (b) images of a 68-year-old... | Download Scientific Diagram
Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications? - MDS Abstracts
Are Frontal Cognitive and Atrophy Patterns Different in PSP and bvFTD? A Comparative Neuropsychological and VBM Study | PLOS ONE
![Progressive supranuclear palsy: myths, misconceptions and facts about PSP | European Parkinson's Disease Association Progressive supranuclear palsy: myths, misconceptions and facts about PSP | European Parkinson's Disease Association](https://www.epda.eu.com/media/2077/psp-hummingbird-image-courtesy-of-dr-brad-boeve-mayo-clinic-rochester-mn-usa.jpg?width=589&height=442)
Progressive supranuclear palsy: myths, misconceptions and facts about PSP | European Parkinson's Disease Association
![18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty | Scientific Reports 18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-76339-0/MediaObjects/41598_2020_76339_Fig1_HTML.png)
18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty | Scientific Reports
![Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors](https://assets.cureus.com/uploads/figure/file/212710/aa4b7b40b1e611eb90a7718fc86ee1e6-Figure-1_900-revised.png)
Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
![Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study | Journal of Neurology, Neurosurgery & Psychiatry Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/89/7/696/F1.large.jpg?width=800&height=600&carousel=1)
Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study | Journal of Neurology, Neurosurgery & Psychiatry
![Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bbbf39f7-ee31-4906-aacc-49e17449c2a6/gr2.jpg)